|
|
Volumn 15, Issue 1, 2001, Pages 1-4
|
|
Gene therapy for human severe combined immunodeficiencies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE DEAMINASE;
BCG VACCINE;
CD3 ANTIGEN;
CD45 ANTIGEN;
CYTOKINE RECEPTOR;
FIBRONECTIN;
FLT3 LIGAND;
INTERLEUKIN 7 RECEPTOR;
KINASE JAK 3;
KINASE ZAP 70;
MACROGOL;
MEGAKARYOCYTE DIFFERENTIATING FACTOR;
NUCLEOSIDE PHOSPHORYLASE;
PHOSPHOTRANSFERASE;
PROTEIN;
PROTEIN RAG 1;
PROTEIN RAG 2;
PROTEIN SUBUNIT;
RECEPTOR SUBUNIT;
STEM CELL FACTOR;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
ALPHA CHAIN;
BETA CHAIN;
CLINICAL TRIAL;
COMBINED IMMUNODEFICIENCY;
DISEASE MODEL;
ENZYME DEFICIENCY;
GENE EXPRESSION;
GENE MUTATION;
GENE THERAPY;
GENE TRANSFER;
GENETIC RECOMBINATION;
GENETIC TRANSDUCTION;
HEMATOPOIETIC STEM CELL;
HUMAN;
MOLONEY LEUKEMIA ONCOVIRUS;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
STEM CELL;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
|
|
EID: 0034897359
PISSN: 10747613
EISSN: None
Source Type: Journal
DOI: 10.1016/S1074-7613(01)00175-3 Document Type: Review |
|
Times cited : (18)
|
|
References (24)
|
